US Broker Ratings

Alkermes plc (ALKS) Stock Analysis: Strong Buy Ratings and a Promising 32% Upside Potential

Alkermes plc (NASDAQ: ALKS), a notable player in the biopharmaceutical industry, is attracting significant attention from investors due to its promising growth potential and strong market positioning. With a market..

Masimo Corporation (MASI) Stock Analysis: 41% Potential Upside Sparks Investor Optimism

Masimo Corporation (MASI), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors looking for growth potential. With a market capitalization of $6.99..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 13.22% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $9.36 billion, this American..

Merck & Company, Inc. (MRK) Investor Outlook: Strong Buy Ratings and Promising Growth in Healthcare

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, has long been a stalwart in the pharmaceutical industry. Its robust market capitalization of $303.26 billion underscores its..

Exact Sciences Corporation (EXAS) Investor Outlook: Navigating Growth in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the healthcare sector, is making waves in the diagnostics and research industry with its innovative cancer screening and diagnostic test products. With..

Chemed Corp (CHE) Stock Analysis: Exploring a 17.39% Potential Upside with Strong Analyst Support

Chemed Corporation (NYSE: CHE) offers a unique proposition in the healthcare sector, presenting investors with a mix of steady revenue growth and robust operational efficiency. With a current market capitalization..

Abbott Laboratories (ABT) Stock Analysis: 18% Potential Upside Beckons Investors

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, has long been a pioneering force in the medical devices industry. With a substantial market capitalization of $196.11 billion, Abbott..

United Therapeutics Corporation (UTHR) Stock Analysis: Promising 12% Upside with Strong Revenue Growth

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents a compelling investment opportunity. With a market capitalization..

Haleon plc (HLN) Stock Analysis: Unveiling the Growth Potential in Consumer Healthcare

Haleon plc (HLN), a prominent player in the healthcare sector, is making waves in the fast-evolving landscape of consumer health products. With a robust market capitalization of $49.87 billion, this..

Teleflex Incorporated (TFX) Stock Analysis: Evaluating a 24.58% Potential Upside Amid Healthcare Innovations

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, specializes in the development and supply of single-use medical devices. With a market capitalization of $4.59 billion, the company..

West Pharmaceutical Services (WST) Stock Analysis: A Look at Its 27% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) is a compelling investment opportunity within the healthcare sector, particularly for those eyeing the medical instruments and supplies industry. With a market capitalization of..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Understanding Its Growth Potential and Market Position

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is a notable player in the biotechnology sector, with a market capitalization of $9.34 billion. Headquartered in San Diego, California, the company specializes in the..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 6.43% Potential Upside and Strong Revenue Growth

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $19.11 billion, the company has..

Molina Healthcare Inc (MOH) Stock Analysis: Evaluating a 19.5% Potential Upside Amidst Market Volatility

Molina Healthcare Inc (NYSE: MOH) stands as a significant player in the healthcare plans industry, focusing on providing managed healthcare services primarily to low-income families and individuals through various government..

HealthEquity, Inc. (HQY) Stock Analysis: Analysts See Potential 61% Upside

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the Health Information Services industry, is capturing investor attention with its robust growth potential and attractive analyst ratings. As a technology-enabled service..

Boston Scientific Corporation (BSX) Stock Analysis: Navigating a 41% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a stalwart in the healthcare sector, is capturing investor attention with an enticing potential upside of 41.05%. Headquartered in Marlborough, Massachusetts, this medical device powerhouse..

Bio-Techne Corp (TECH): Investor Outlook Highlights 25.56% Potential Upside with Strong Buy Ratings

Bio-Techne Corp (NASDAQ: TECH) stands as a noteworthy player in the biotechnology industry, reflecting its robust market presence with a market capitalization of $9.38 billion. Based in Minneapolis, Minnesota, Bio-Techne..

Incyte Corporation (INCY) Stock Analysis: A Biotech Giant with Growth Potential and 29.87% ROE

Incyte Corporation (NASDAQ: INCY) stands as a formidable player in the biotechnology sector, appealing to investors with its robust growth metrics and innovative portfolio. Headquartered in Wilmington, Delaware, Incyte is..

The Cigna Group (CI) Stock Analysis: Poised for a 14% Upside with Strong Buy Ratings

The Cigna Group (NYSE: CI), a formidable presence in the healthcare sector, stands out as a compelling investment opportunity. With a market cap of $77.85 billion, Cigna is a titan..

Glaukos Corporation (GKOS) Investor Outlook: Analyzing the 21% Potential Upside Amid Robust Revenue Growth

Glaukos Corporation (NYSE: GKOS) is making waves in the healthcare sector, specifically within the medical devices industry, with its innovative approach to treating ocular disorders. Based in Aliso Viejo, California,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds